Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation
To compare the different stem cell sources used in salvage transplantation for graft failure (GF) after cord blood transplantation (CBT), we retrospectively analyzed data of 220 patients who developed GF after undergoing CBT between January 2001 and December 2007 and underwent a second hematopoietic...
Gespeichert in:
| Veröffentlicht in: | Biology of blood and marrow transplantation 2012-09, Vol.18 (9), p.1407-1414 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1414 |
|---|---|
| container_issue | 9 |
| container_start_page | 1407 |
| container_title | Biology of blood and marrow transplantation |
| container_volume | 18 |
| creator | Fuji, Shigeo Nakamura, Fumiaki Hatanaka, Kazuo Taniguchi, Shuichi Sato, Maho Mori, Shin-ichiro Sakamaki, Hisashi Yabe, Hiromasa Miyamoto, Toshihiro Kanamori, Heiwa Ueda, Yasunori Kawa, Keisei Kato, Koji Suzuki, Ritsuro Atsuta, Yoshiko Tamaki, Toshiharu Kanda, Yoshinobu |
| description | To compare the different stem cell sources used in salvage transplantation for graft failure (GF) after cord blood transplantation (CBT), we retrospectively analyzed data of 220 patients who developed GF after undergoing CBT between January 2001 and December 2007 and underwent a second hematopoietic stem cell transplantation (HSCT) within 3 months. The donor sources for salvage HSCT were cord blood (n = 180), peripheral blood stem cells (PBSCs; n = 24), and bone marrow (BM; n = 16). The cumulative incidence of neutrophil engraftment on day 30 after the second HSCT was 39% with CB, 71% with PBSCs, and 75% with BM. Multivariate analysis revealed that PBSC and BM grafts were associated with a significantly higher engraftment rate than CB (hazard ratio [HR], 7.77; P < .001 and HR, 2.81; P = .016, respectively). Although the incidence of grade II-IV acute graft-versus-host disease was significantly higher in the PBSC group than in the CB group (HR, 2.83; P = .011), the incidence of 1-year nonrelapse mortality was lower in the PBSC group than in the CB group (HR, 0.43; P = .019), and 1-year overall survival was superior in the PBSC group compared with the CB group (HR, 0.45; P = .036). Our results suggest that PBSC is the preferable source of stem cells in salvage HSCT for GF after CBT. |
| doi_str_mv | 10.1016/j.bbmt.2012.02.014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1034514826</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1083879112001127</els_id><sourcerecordid>1034514826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-fa503a1b981306d49dfe026f0fff1089d6b2f85732f055f5b86b7f544e399d913</originalsourceid><addsrcrecordid>eNp9Uk2P0zAQjRCIXRb-AAfkI5cWf8RpghBSKewuaCUqupwtJxlvXZw4a7tF_fUw2XY59IBk2aPxe-PneZNlrxmdMsqKd5tpXXdpyinjU4qL5U-ycya5mBRSFE8xpqWYlLOKnWUvYtxQSmd5WT3PzjjPBaVlcZ79WUKwwxqCduST874lOhJNlgEM5moHZOW3oQHiDVkl6MgCnIvE-EBW2u30HZDboPs4ON0nnazvie3JEiPoUyS_bVqTq6BNIpfaum0AgjEEsvChPT54wn9P5uQHpODjAE2yOyDzXrt9tHHUkNaAt3c2prAnn3XSj8lvetA9xFFvYyHtHyReQ6eTHzwmbPMg_fS1l9kzo12EV8fzIvt5-eV2cT25-X71dTG_mTS5lGlitKRCs7oqmaBFm1etAcoLQ40x2OWqLWpuSjkT3FApjazLop4ZmecgqqqtmLjI3h7qDsHfbyEm1dnYoCAU7bdRMSpyyfKSFwjlB2iDPYhohBqC7XTYI0iNxquNGo1Xo_GK4mI5kt4c62_rDtp_lEenEfDhAAD85c5CUBH71DfQ2oB9Vq23_6__8YTeONvbRrtfsIe4wSFBl_AfKiJBrcbRGyePcUpxm4m_oQHZIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1034514826</pqid></control><display><type>article</type><title>Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Fuji, Shigeo ; Nakamura, Fumiaki ; Hatanaka, Kazuo ; Taniguchi, Shuichi ; Sato, Maho ; Mori, Shin-ichiro ; Sakamaki, Hisashi ; Yabe, Hiromasa ; Miyamoto, Toshihiro ; Kanamori, Heiwa ; Ueda, Yasunori ; Kawa, Keisei ; Kato, Koji ; Suzuki, Ritsuro ; Atsuta, Yoshiko ; Tamaki, Toshiharu ; Kanda, Yoshinobu</creator><creatorcontrib>Fuji, Shigeo ; Nakamura, Fumiaki ; Hatanaka, Kazuo ; Taniguchi, Shuichi ; Sato, Maho ; Mori, Shin-ichiro ; Sakamaki, Hisashi ; Yabe, Hiromasa ; Miyamoto, Toshihiro ; Kanamori, Heiwa ; Ueda, Yasunori ; Kawa, Keisei ; Kato, Koji ; Suzuki, Ritsuro ; Atsuta, Yoshiko ; Tamaki, Toshiharu ; Kanda, Yoshinobu</creatorcontrib><description>To compare the different stem cell sources used in salvage transplantation for graft failure (GF) after cord blood transplantation (CBT), we retrospectively analyzed data of 220 patients who developed GF after undergoing CBT between January 2001 and December 2007 and underwent a second hematopoietic stem cell transplantation (HSCT) within 3 months. The donor sources for salvage HSCT were cord blood (n = 180), peripheral blood stem cells (PBSCs; n = 24), and bone marrow (BM; n = 16). The cumulative incidence of neutrophil engraftment on day 30 after the second HSCT was 39% with CB, 71% with PBSCs, and 75% with BM. Multivariate analysis revealed that PBSC and BM grafts were associated with a significantly higher engraftment rate than CB (hazard ratio [HR], 7.77; P < .001 and HR, 2.81; P = .016, respectively). Although the incidence of grade II-IV acute graft-versus-host disease was significantly higher in the PBSC group than in the CB group (HR, 2.83; P = .011), the incidence of 1-year nonrelapse mortality was lower in the PBSC group than in the CB group (HR, 0.43; P = .019), and 1-year overall survival was superior in the PBSC group compared with the CB group (HR, 0.45; P = .036). Our results suggest that PBSC is the preferable source of stem cells in salvage HSCT for GF after CBT.</description><identifier>ISSN: 1083-8791</identifier><identifier>EISSN: 1523-6536</identifier><identifier>DOI: 10.1016/j.bbmt.2012.02.014</identifier><identifier>PMID: 22430086</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Disease ; Adolescent ; Adult ; Bone Marrow Transplantation ; Cord Blood Stem Cell Transplantation ; Engraftment ; Female ; Graft Rejection - immunology ; Graft Rejection - prevention & control ; Graft vs Host Disease - immunology ; Graft vs Host Disease - mortality ; Graft vs Host Disease - therapy ; Hematology, Oncology and Palliative Medicine ; Humans ; Japan ; Leukemia - immunology ; Leukemia - mortality ; Leukemia - therapy ; Lymphoma - immunology ; Lymphoma - mortality ; Lymphoma - therapy ; Male ; Multivariate Analysis ; Neutrophils - immunology ; Peripheral Blood Stem Cell Transplantation ; Peripheral blood stem cells ; Recurrence ; Registries ; Retrospective Studies ; Second transplant ; Societies, Medical ; Survival Analysis ; Transplantation Conditioning</subject><ispartof>Biology of blood and marrow transplantation, 2012-09, Vol.18 (9), p.1407-1414</ispartof><rights>American Society for Blood and Marrow Transplantation</rights><rights>2012 American Society for Blood and Marrow Transplantation</rights><rights>Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-fa503a1b981306d49dfe026f0fff1089d6b2f85732f055f5b86b7f544e399d913</citedby><cites>FETCH-LOGICAL-c455t-fa503a1b981306d49dfe026f0fff1089d6b2f85732f055f5b86b7f544e399d913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1083879112001127$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22430086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fuji, Shigeo</creatorcontrib><creatorcontrib>Nakamura, Fumiaki</creatorcontrib><creatorcontrib>Hatanaka, Kazuo</creatorcontrib><creatorcontrib>Taniguchi, Shuichi</creatorcontrib><creatorcontrib>Sato, Maho</creatorcontrib><creatorcontrib>Mori, Shin-ichiro</creatorcontrib><creatorcontrib>Sakamaki, Hisashi</creatorcontrib><creatorcontrib>Yabe, Hiromasa</creatorcontrib><creatorcontrib>Miyamoto, Toshihiro</creatorcontrib><creatorcontrib>Kanamori, Heiwa</creatorcontrib><creatorcontrib>Ueda, Yasunori</creatorcontrib><creatorcontrib>Kawa, Keisei</creatorcontrib><creatorcontrib>Kato, Koji</creatorcontrib><creatorcontrib>Suzuki, Ritsuro</creatorcontrib><creatorcontrib>Atsuta, Yoshiko</creatorcontrib><creatorcontrib>Tamaki, Toshiharu</creatorcontrib><creatorcontrib>Kanda, Yoshinobu</creatorcontrib><title>Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation</title><title>Biology of blood and marrow transplantation</title><addtitle>Biol Blood Marrow Transplant</addtitle><description>To compare the different stem cell sources used in salvage transplantation for graft failure (GF) after cord blood transplantation (CBT), we retrospectively analyzed data of 220 patients who developed GF after undergoing CBT between January 2001 and December 2007 and underwent a second hematopoietic stem cell transplantation (HSCT) within 3 months. The donor sources for salvage HSCT were cord blood (n = 180), peripheral blood stem cells (PBSCs; n = 24), and bone marrow (BM; n = 16). The cumulative incidence of neutrophil engraftment on day 30 after the second HSCT was 39% with CB, 71% with PBSCs, and 75% with BM. Multivariate analysis revealed that PBSC and BM grafts were associated with a significantly higher engraftment rate than CB (hazard ratio [HR], 7.77; P < .001 and HR, 2.81; P = .016, respectively). Although the incidence of grade II-IV acute graft-versus-host disease was significantly higher in the PBSC group than in the CB group (HR, 2.83; P = .011), the incidence of 1-year nonrelapse mortality was lower in the PBSC group than in the CB group (HR, 0.43; P = .019), and 1-year overall survival was superior in the PBSC group compared with the CB group (HR, 0.45; P = .036). Our results suggest that PBSC is the preferable source of stem cells in salvage HSCT for GF after CBT.</description><subject>Acute Disease</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Bone Marrow Transplantation</subject><subject>Cord Blood Stem Cell Transplantation</subject><subject>Engraftment</subject><subject>Female</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - prevention & control</subject><subject>Graft vs Host Disease - immunology</subject><subject>Graft vs Host Disease - mortality</subject><subject>Graft vs Host Disease - therapy</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Japan</subject><subject>Leukemia - immunology</subject><subject>Leukemia - mortality</subject><subject>Leukemia - therapy</subject><subject>Lymphoma - immunology</subject><subject>Lymphoma - mortality</subject><subject>Lymphoma - therapy</subject><subject>Male</subject><subject>Multivariate Analysis</subject><subject>Neutrophils - immunology</subject><subject>Peripheral Blood Stem Cell Transplantation</subject><subject>Peripheral blood stem cells</subject><subject>Recurrence</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Second transplant</subject><subject>Societies, Medical</subject><subject>Survival Analysis</subject><subject>Transplantation Conditioning</subject><issn>1083-8791</issn><issn>1523-6536</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uk2P0zAQjRCIXRb-AAfkI5cWf8RpghBSKewuaCUqupwtJxlvXZw4a7tF_fUw2XY59IBk2aPxe-PneZNlrxmdMsqKd5tpXXdpyinjU4qL5U-ycya5mBRSFE8xpqWYlLOKnWUvYtxQSmd5WT3PzjjPBaVlcZ79WUKwwxqCduST874lOhJNlgEM5moHZOW3oQHiDVkl6MgCnIvE-EBW2u30HZDboPs4ON0nnazvie3JEiPoUyS_bVqTq6BNIpfaum0AgjEEsvChPT54wn9P5uQHpODjAE2yOyDzXrt9tHHUkNaAt3c2prAnn3XSj8lvetA9xFFvYyHtHyReQ6eTHzwmbPMg_fS1l9kzo12EV8fzIvt5-eV2cT25-X71dTG_mTS5lGlitKRCs7oqmaBFm1etAcoLQ40x2OWqLWpuSjkT3FApjazLop4ZmecgqqqtmLjI3h7qDsHfbyEm1dnYoCAU7bdRMSpyyfKSFwjlB2iDPYhohBqC7XTYI0iNxquNGo1Xo_GK4mI5kt4c62_rDtp_lEenEfDhAAD85c5CUBH71DfQ2oB9Vq23_6__8YTeONvbRrtfsIe4wSFBl_AfKiJBrcbRGyePcUpxm4m_oQHZIw</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Fuji, Shigeo</creator><creator>Nakamura, Fumiaki</creator><creator>Hatanaka, Kazuo</creator><creator>Taniguchi, Shuichi</creator><creator>Sato, Maho</creator><creator>Mori, Shin-ichiro</creator><creator>Sakamaki, Hisashi</creator><creator>Yabe, Hiromasa</creator><creator>Miyamoto, Toshihiro</creator><creator>Kanamori, Heiwa</creator><creator>Ueda, Yasunori</creator><creator>Kawa, Keisei</creator><creator>Kato, Koji</creator><creator>Suzuki, Ritsuro</creator><creator>Atsuta, Yoshiko</creator><creator>Tamaki, Toshiharu</creator><creator>Kanda, Yoshinobu</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120901</creationdate><title>Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation</title><author>Fuji, Shigeo ; Nakamura, Fumiaki ; Hatanaka, Kazuo ; Taniguchi, Shuichi ; Sato, Maho ; Mori, Shin-ichiro ; Sakamaki, Hisashi ; Yabe, Hiromasa ; Miyamoto, Toshihiro ; Kanamori, Heiwa ; Ueda, Yasunori ; Kawa, Keisei ; Kato, Koji ; Suzuki, Ritsuro ; Atsuta, Yoshiko ; Tamaki, Toshiharu ; Kanda, Yoshinobu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-fa503a1b981306d49dfe026f0fff1089d6b2f85732f055f5b86b7f544e399d913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute Disease</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Bone Marrow Transplantation</topic><topic>Cord Blood Stem Cell Transplantation</topic><topic>Engraftment</topic><topic>Female</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - prevention & control</topic><topic>Graft vs Host Disease - immunology</topic><topic>Graft vs Host Disease - mortality</topic><topic>Graft vs Host Disease - therapy</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Japan</topic><topic>Leukemia - immunology</topic><topic>Leukemia - mortality</topic><topic>Leukemia - therapy</topic><topic>Lymphoma - immunology</topic><topic>Lymphoma - mortality</topic><topic>Lymphoma - therapy</topic><topic>Male</topic><topic>Multivariate Analysis</topic><topic>Neutrophils - immunology</topic><topic>Peripheral Blood Stem Cell Transplantation</topic><topic>Peripheral blood stem cells</topic><topic>Recurrence</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Second transplant</topic><topic>Societies, Medical</topic><topic>Survival Analysis</topic><topic>Transplantation Conditioning</topic><toplevel>online_resources</toplevel><creatorcontrib>Fuji, Shigeo</creatorcontrib><creatorcontrib>Nakamura, Fumiaki</creatorcontrib><creatorcontrib>Hatanaka, Kazuo</creatorcontrib><creatorcontrib>Taniguchi, Shuichi</creatorcontrib><creatorcontrib>Sato, Maho</creatorcontrib><creatorcontrib>Mori, Shin-ichiro</creatorcontrib><creatorcontrib>Sakamaki, Hisashi</creatorcontrib><creatorcontrib>Yabe, Hiromasa</creatorcontrib><creatorcontrib>Miyamoto, Toshihiro</creatorcontrib><creatorcontrib>Kanamori, Heiwa</creatorcontrib><creatorcontrib>Ueda, Yasunori</creatorcontrib><creatorcontrib>Kawa, Keisei</creatorcontrib><creatorcontrib>Kato, Koji</creatorcontrib><creatorcontrib>Suzuki, Ritsuro</creatorcontrib><creatorcontrib>Atsuta, Yoshiko</creatorcontrib><creatorcontrib>Tamaki, Toshiharu</creatorcontrib><creatorcontrib>Kanda, Yoshinobu</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biology of blood and marrow transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fuji, Shigeo</au><au>Nakamura, Fumiaki</au><au>Hatanaka, Kazuo</au><au>Taniguchi, Shuichi</au><au>Sato, Maho</au><au>Mori, Shin-ichiro</au><au>Sakamaki, Hisashi</au><au>Yabe, Hiromasa</au><au>Miyamoto, Toshihiro</au><au>Kanamori, Heiwa</au><au>Ueda, Yasunori</au><au>Kawa, Keisei</au><au>Kato, Koji</au><au>Suzuki, Ritsuro</au><au>Atsuta, Yoshiko</au><au>Tamaki, Toshiharu</au><au>Kanda, Yoshinobu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation</atitle><jtitle>Biology of blood and marrow transplantation</jtitle><addtitle>Biol Blood Marrow Transplant</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>18</volume><issue>9</issue><spage>1407</spage><epage>1414</epage><pages>1407-1414</pages><issn>1083-8791</issn><eissn>1523-6536</eissn><abstract>To compare the different stem cell sources used in salvage transplantation for graft failure (GF) after cord blood transplantation (CBT), we retrospectively analyzed data of 220 patients who developed GF after undergoing CBT between January 2001 and December 2007 and underwent a second hematopoietic stem cell transplantation (HSCT) within 3 months. The donor sources for salvage HSCT were cord blood (n = 180), peripheral blood stem cells (PBSCs; n = 24), and bone marrow (BM; n = 16). The cumulative incidence of neutrophil engraftment on day 30 after the second HSCT was 39% with CB, 71% with PBSCs, and 75% with BM. Multivariate analysis revealed that PBSC and BM grafts were associated with a significantly higher engraftment rate than CB (hazard ratio [HR], 7.77; P < .001 and HR, 2.81; P = .016, respectively). Although the incidence of grade II-IV acute graft-versus-host disease was significantly higher in the PBSC group than in the CB group (HR, 2.83; P = .011), the incidence of 1-year nonrelapse mortality was lower in the PBSC group than in the CB group (HR, 0.43; P = .019), and 1-year overall survival was superior in the PBSC group compared with the CB group (HR, 0.45; P = .036). Our results suggest that PBSC is the preferable source of stem cells in salvage HSCT for GF after CBT.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22430086</pmid><doi>10.1016/j.bbmt.2012.02.014</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1083-8791 |
| ispartof | Biology of blood and marrow transplantation, 2012-09, Vol.18 (9), p.1407-1414 |
| issn | 1083-8791 1523-6536 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1034514826 |
| source | MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Acute Disease Adolescent Adult Bone Marrow Transplantation Cord Blood Stem Cell Transplantation Engraftment Female Graft Rejection - immunology Graft Rejection - prevention & control Graft vs Host Disease - immunology Graft vs Host Disease - mortality Graft vs Host Disease - therapy Hematology, Oncology and Palliative Medicine Humans Japan Leukemia - immunology Leukemia - mortality Leukemia - therapy Lymphoma - immunology Lymphoma - mortality Lymphoma - therapy Male Multivariate Analysis Neutrophils - immunology Peripheral Blood Stem Cell Transplantation Peripheral blood stem cells Recurrence Registries Retrospective Studies Second transplant Societies, Medical Survival Analysis Transplantation Conditioning |
| title | Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T10%3A22%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peripheral%20Blood%20as%20a%20Preferable%20Source%20of%20Stem%20Cells%20for%20Salvage%20Transplantation%20in%20Patients%20with%20Graft%20Failure%20after%20Cord%20Blood%20Transplantation:%20A%20Retrospective%20Analysis%20of%20the%20Registry%20Data%20of%20the%20Japanese%20Society%20for%20Hematopoietic%20Cell%20Transplantation&rft.jtitle=Biology%20of%20blood%20and%20marrow%20transplantation&rft.au=Fuji,%20Shigeo&rft.date=2012-09-01&rft.volume=18&rft.issue=9&rft.spage=1407&rft.epage=1414&rft.pages=1407-1414&rft.issn=1083-8791&rft.eissn=1523-6536&rft_id=info:doi/10.1016/j.bbmt.2012.02.014&rft_dat=%3Cproquest_cross%3E1034514826%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1034514826&rft_id=info:pmid/22430086&rft_els_id=S1083879112001127&rfr_iscdi=true |